Hypothermia Due to Cold EnvironmentNCT06788925
Clinical Evaluation of Effectiveness of the "Therm'Up" Heating Device
A study testing Patients support with survival coverage and Patients support with active thermic jacket in people with Hypothermia Due to Cold Environment, run by ThermoTrauma at 1 site in France.
Trial summary
Here's a concise summary in English without the numbers: Hypothermia is defined as a core temperature below 35°C and occurs when the body loses more heat than it produces. It is classified by severity: mild (32-35°C), moderate (28-32°C), and severe (<28°C). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hypothermia Due to Cold Environment
- What is being tested?
- Patients support with survival coverage and Patients support with active thermic jacket
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteFrance
- Study dates
- 5 Apr 2025to 30 Mar 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥ 18 years; Confi dential Page 7on 11 Version No. 2.0 of 2024/12/10
- Patient at risk of hypothermia presenting with grade A, or B, or C trauma or patient with hypothermia;
- Patient exposed to cold;
- Patient with hemorrhage;
- Patient burned over 20% of body surface area;
- Patient requiring an intervention delay of more than 30 minutes (between the arrival of the medical team on site and arrival at the hospital)
Who cannot join
- Patient with known ongoing hyperthermia and/or infections or body injuries such as burns in the area where the breastplate is positioned;
- Patient presenting with cardiac arrest before the arrival of the team;
- Patient with bilateral aural bleeding preventing continuous monitoring of the eardrum;
- Patient covered with insulating bubble wrap;
- Pregnant or breastfeeding woman;
- Patient already participating in an interventional clinical trial;
- Patient not receiving social security benefi ts;
- Adult patient subject to a legal protection measure, guardianship or deprived of liberty by a judicial or administrative decision.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Clinical Evaluation of an Innovative Hypothermia Management Strategy in Trauma Patients: Effectiveness of the Therm'Up Heating Device
Here's a concise summary in English without the numbers:
Hypothermia is defined as a core temperature below 35°C and occurs when the body loses more heat than it produces. It is classified by severity: mild (32-35°C), moderate (28-32°C), and severe (<28°C). Trauma patients are particularly vulnerable, as hypothermia can affect cardiac, pulmonary, neurological, and coagulation systems, contributing to the "lethal triad" of metabolic acidosis, coagulopathy, and hypothermia, which increases early mortality risk.
Shivering, a key sign of hypothermia, significantly raises oxygen consumption, making its prevention during prehospital care critical. Passive warming measures, such as insulating survival blankets, are commonly used to prevent heat loss in emergencies. These blankets help maintain body temperature, protecting victims from cold and wind. Hypothermia prevalence among trauma patients on hospital arrival is high, emphasizing the importance of prehospital measures to limit its impact. However, active warming systems are often impractical in prehospital settings, leaving passive methods as the primary strategy.
Read the detailed description
Hypothermia is defi ned as a core temperature below 35°C. Accidental hypothermia occurs when the human body loses more heat than it produces, resulting in a drop in body temperature.
Core body temperature is the standard physiological parameter for diagnosing and classifying the severity of hypothermia. Mild accidental hypothermia is defi ned as a core body temperature between 32 and 35°C, moderate hypothermia as a core temperature between 28 and 32°C, and severe hypothermia as a core temperature <28°C.
Trauma patients are at high risk of accidental hypothermia (body temperature ≤ 35°C). Hypothermia has signifi cant consequences on human physiology, including the cardiac, pulmonary, neurological, and hemostatic systems.
Hypothermia is of particular concern in trauma patients because it is associated with increased morbidity and mortality. In addition, hypothermia can infl uence blood coagulation by reducing platelet aggregation and increasing fi brinolysis. Three closely related elements: metabolic acidosis, coagulopathy, and hypothermia constitute the "lethal triad" of trauma. The presence of one or more of these elements during the management of a severely traumatized patient increases the risk of early mortality.
The occurrence of shivering in a patient is also an indicator of hypothermia. Shivering can increase oxygen consumption of muscle cells by up to 400%. The goal of prehospital care is to prevent the onset of shivering, making the use of passive warming measures crucial.
In a systematic review, the prevalence of hypothermia in trauma victims on arrival at hospital was found to be high, at 14%.
An observational study conducted by the SMUR (Mobile Emergency and Resuscitation Services) team of eight French hospitals between January 1, 2004 and November 10, 2007, measured the body temperature of 448 patients upon arrival at the hospital. Hypothermia (body temperature ≤ 35°C) was present in 64 of these 448 patients (14%). Optimal patient care can help limit heat loss or hypothermia. It is important to note that the prolonged time required to recover patients after a road accident increases the risk of lasting hypothermia. This hypothermia, linked to the accident, is associated with an increased mortality rate in severely injured patients, which underlines the importance of prehospital efforts to prevent hypothermia.
Prevention of hypothermia in trauma patients in the prehospital care setting is of critical importance. Various devices have been designed to reduce heat loss and/or actively warm patients in a prehospital environment.
Warming strategies are not ideally suited to pre-hospital care due to the complexity of their implementation and their inadequacy to the conditions encountered. Active external systems generate heat transferred to the patient, while passive systems isolate the patient by preventing the dispersion of body heat.
In most cases, passive warming methods are used, such as the use of insulating survival blankets, which still allow the patient to be insulated from the cold. The insulating survival blanket is used in emergency situations to cover a victim and prevent hypothermia. It is an essential product in the event of illness or accident (trauma, fall, etc.), or in the event of a sudden change in temperature, to maintain the victim's body temperature, protect them from the cold and wind and prevent hypothermia. These so-called "isothermal" blankets allow the body temperature to be maintained at around 37°C.
Active external warming is only possible with chemical, electrical methods or warm air blankets, but these are diffi cult to access before arrival at the hospital due to their high cost, their signifi cant environmental impact (single use) and their unsuitability for outdoor use. However, only proactive and early administration of heat can effectively combat hypothermia and its consequences. The use of a heated blanket or better still, a warm air mattress, is much more effective and allows to gain 1 to 2 °C of core temperature per hour. In out-of-hospital and mountain rescue environments, measuring core temperature can guide transport and treatment decisions, although obtaining an accurate value can be difficult.
Developing alternatives to current devices would reduce health risks and allow targeted intervention to control core temperature, thereby preventing or reducing the harmful consequences of hypothermia. This type of innovation would also have the potential to reduce the risks and limitations associated with existing technical procedures. Hence the objective of this clinical investigation to assess the non-inferiority of a new Therm'Up device compared to the survival blanket to prevent hypothermia in trauma patients in prehospital care.
- Conditions
- Hypothermia Due to Cold Environment
- Being tested
- Patients support with survival coverage, Patients support with active thermic jacket
- Keywords
- Hypothermia, Lifejacket, Active device
- Medical subject headings
- Hypothermia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Patients support with survival coverageDevice
Following calls to emergency medical services, handled by the ground SMUR/SAMU or the air SMUR (HéliSMUR), the operator collects essential information on the nature of the incident and the apparent condition of the injured. A medical team is thus mobilized on site. It takes over from the rescue team (e.g. the SDIS fi refi ghters) who are generally the fi rst to arrive on the scene.
Eligible patients will be randomly assigned consecutively to one of two groups: control (use of the survival blanket) and experimental (use of the Therm'Up breastplate).
Any traumatized person at risk of hypothermia or in hypothermia in a pre-hospital environment, having given verbal consent to participate in the study and meeting the inclusion criteria
Patients support with active thermic jacketDevice
The intervention Description is exactly the same, except that the patient will be given a ThermUp jacket
| Study group | Role | What they receive |
|---|---|---|
| Experimental Arm with ThermUp chest protector | Experimental | Patients benefi ting from the Therm'Up heated chest protector Receives: Device: Patients support with active thermic jacket |
| Control Arm with blanket | Active comparator | Patients supported with survival coverage (conventional PEC). Receives: Device: Patients support with survival coverage |
What is being measured
The primary outcome is the main question the study is designed to answer.
Statistical distribution of the temperature evolution
The statistical distribution of the temperature evolution will be tested to verify whether it follows a normal distribution. The Shapiro-Wilk test and graphical methods will be used to assess this normality.
Measured: From the intervention of the medical team on site until discharge from the hospital (1 month maximum)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jan 2025
- Study start5 Apr 2025
- Primary completion30 Mar 2026 (estimated)
- Study completion30 Mar 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hypothermia Due to Cold EnvironmentStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- ThermoTrauma
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Digital Medical Hub, Chambery Hospital, France, Centre Hospitalier Annecy Genevois, University Hospital, Grenoble
- Responsible party
- Sponsor
- Investigators
- Thomas Spadoni, Study director, Thermotrauma SAS
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06788925
- Sponsor's protocol ID
- 2024-A02412-45
- Status last verified
- Jan 2026
- First submitted
- 17 Jan 2025
- Last updated
- 14 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: According to European Regulation on Data Protection (GDPR, 2016/679, April 2016), we are not allowed to share patients data
Study at a glance
From the registry record, last updated by the sponsor on 14 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Evaluation of an Innovative Hypothermia Management Strategy in Trauma Patients: Effectiveness of the Therm'Up Heating Device
- ClinicalTrials.gov ID
- NCT06788925
- Acronym / sponsor ID
- 2024-A02412-45
- Conditions
- Hypothermia Due to Cold Environment
- Keywords
- Hypothermia, Lifejacket, Active device
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- ThermoTraumaIndustry (pharma, biotech, devices)
- Collaborators
- Digital Medical Hub, Chambery Hospital, France, Centre Hospitalier Annecy Genevois, University Hospital, Grenoble
- Study start
- 5 Apr 2025 (actual)
- Primary completion
- 30 Mar 2026 (estimated)
- Study completion
- 30 Mar 2026 (estimated)
- First posted
- 23 Jan 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Here's a concise summary in English without the numbers:
Hypothermia is defined as a core temperature below 35°C and occurs when the body loses more heat than it produces. It is classified by severity: mild (32-35°C), moderate (28-32°C), and severe (<28°C). Trauma patients are particularly vulnerable, as hypothermia can affect cardiac, pulmonary, neurological, and coagulation systems, contributing to the "lethal triad" of metabolic acidosis, coagulopathy, and hypothermia, which increases early mortality risk.
Shivering, a key sign of hypothermia, significantly raises oxygen consumption, making its prevention during prehospital care critical. Passive warming measures, such as insulating survival blankets, are commonly used to prevent heat loss in emergencies. These blankets help maintain body temperature, protecting victims from cold and wind. Hypothermia prevalence among trauma patients on hospital arrival is high, emphasizing the importance of prehospital measures to limit its impact. However, active warming systems are often impractical in prehospital settings, leaving passive methods as the primary strategy.
Detailed description
Hypothermia is defi ned as a core temperature below 35°C. Accidental hypothermia occurs when the human body loses more heat than it produces, resulting in a drop in body temperature.
Core body temperature is the standard physiological parameter for diagnosing and classifying the severity of hypothermia. Mild accidental hypothermia is defi ned as a core body temperature between 32 and 35°C, moderate hypothermia as a core temperature between 28 and 32°C, and severe hypothermia as a core temperature <28°C.
Trauma patients are at high risk of accidental hypothermia (body temperature ≤ 35°C). Hypothermia has signifi cant consequences on human physiology, including the cardiac, pulmonary, neurological, and hemostatic systems.
Hypothermia is of particular concern in trauma patients because it is associated with increased morbidity and mortality. In addition, hypothermia can infl uence blood coagulation by reducing platelet aggregation and increasing fi brinolysis. Three closely related elements: metabolic acidosis, coagulopathy, and hypothermia constitute the "lethal triad" of trauma. The presence of one or more of these elements during the management of a severely traumatized patient increases the risk of early mortality.
The occurrence of shivering in a patient is also an indicator of hypothermia. Shivering can increase oxygen consumption of muscle cells by up to 400%. The goal of prehospital care is to prevent the onset of shivering, making the use of passive warming measures crucial.
In a systematic review, the prevalence of hypothermia in trauma victims on arrival at hospital was found to be high, at 14%.
An observational study conducted by the SMUR (Mobile Emergency and Resuscitation Services) team of eight French hospitals between January 1, 2004 and November 10, 2007, measured the body temperature of 448 patients upon arrival at the hospital. Hypothermia (body temperature ≤ 35°C) was present in 64 of these 448 patients (14%). Optimal patient care can help limit heat loss or hypothermia. It is important to note that the prolonged time required to recover patients after a road accident increases the risk of lasting hypothermia. This hypothermia, linked to the accident, is associated with an increased mortality rate in severely injured patients, which underlines the importance of prehospital efforts to prevent hypothermia.
Prevention of hypothermia in trauma patients in the prehospital care setting is of critical importance. Various devices have been designed to reduce heat loss and/or actively warm patients in a prehospital environment.
Warming strategies are not ideally suited to pre-hospital care due to the complexity of their implementation and their inadequacy to the conditions encountered. Active external systems generate heat transferred to the patient, while passive systems isolate the patient by preventing the dispersion of body heat.
In most cases, passive warming methods are used, such as the use of insulating survival blankets, which still allow the patient to be insulated from the cold. The insulating survival blanket is used in emergency situations to cover a victim and prevent hypothermia. It is an essential product in the event of illness or accident (trauma, fall, etc.), or in the event of a sudden change in temperature, to maintain the victim's body temperature, protect them from the cold and wind and prevent hypothermia. These so-called "isothermal" blankets allow the body temperature to be maintained at around 37°C.
Active external warming is only possible with chemical, electrical methods or warm air blankets, but these are diffi cult to access before arrival at the hospital due to their high cost, their signifi cant environmental impact (single use) and their unsuitability for outdoor use. However, only proactive and early administration of heat can effectively combat hypothermia and its consequences. The use of a heated blanket or better still, a warm air mattress, is much more effective and allows to gain 1 to 2 °C of core temperature per hour. In out-of-hospital and mountain rescue environments, measuring core temperature can guide transport and treatment decisions, although obtaining an accurate value can be difficult.
Developing alternatives to current devices would reduce health risks and allow targeted intervention to control core temperature, thereby preventing or reducing the harmful consequences of hypothermia. This type of innovation would also have the potential to reduce the risks and limitations associated with existing technical procedures. Hence the objective of this clinical investigation to assess the non-inferiority of a new Therm'Up device compared to the survival blanket to prevent hypothermia in trauma patients in prehospital care.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Experimental Arm with ThermUp chest protector | Experimental | Device: Patients support with active thermic jacketPatients benefi ting from the Therm'Up heated chest protector |
| Control Arm with blanket | Active comparator | Device: Patients support with survival coveragePatients supported with survival coverage (conventional PEC). |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Age ≥ 18 years; Confi dential Page 7on 11 Version No. 2.0 of 2024/12/10
- Patient at risk of hypothermia presenting with grade A, or B, or C trauma or patient with hypothermia;
- Patient exposed to cold;
- Patient with hemorrhage;
- Patient burned over 20% of body surface area;
Key exclusion criteria (8 listed)
- Patient with known ongoing hyperthermia and/or infections or body injuries such as burns in the area where the breastplate is positioned;
- Patient presenting with cardiac arrest before the arrival of the team;
- Patient with bilateral aural bleeding preventing continuous monitoring of the eardrum;
- Patient covered with insulating bubble wrap;
- Pregnant or breastfeeding woman;
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Patients support with survival coverageFollowing calls to emergency medical services, handled by the ground SMUR/SAMU or the air SMUR (HéliSMUR), the operator collects essential information on the nature of the incident and the apparent condition of the injured. A medical team is thus mobilized on site. It takes over from the rescue team (e.g. the SDIS fi refi ghters) who are generally the fi rst to arrive on the scene. Eligible patients will be randomly assigned consecutively to one of two groups: control (use of the survival blanket) and experimental (use of the Therm'Up breastplate). Any traumatized person at risk of hypothermia or in hypothermia in a pre-hospital environment, having given verbal consent to participate in the study and meeting the inclusion criteria | Device | Control Arm with blanket |
| Patients support with active thermic jacketThe intervention Description is exactly the same, except that the patient will be given a ThermUp jacket | Device | Experimental Arm with ThermUp chest protector |
Primary outcome
Statistical distribution of the temperature evolution
Time frame: From the intervention of the medical team on site until discharge from the hospital (1 month maximum)
The statistical distribution of the temperature evolution will be tested to verify whether it follows a normal distribution. The Shapiro-Wilk test and graphical methods will be used to assess this normality.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jan 2026.
- Official website of the device (active jacket)Link provided by the sponsor.
- Individual participant dataSharing planned: No. According to European Regulation on Data Protection (GDPR, 2016/679, April 2016), we are not allowed to share patients data
Related trials for Hypothermia Due to Cold Environment
Enrolling by invitation
Pulmonary Function by Litter Position
Hypothermia Due to Cold Environment, Trauma Patients
Enrolling by invitation
Prehospital Use of Forced Air Warming
Hypothermia Due to Cold Environment
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Thomas Spadoni study director
Thermotrauma SAS
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Patients support with survival coverage and Patients support with active thermic jacket in people with Hypothermia Due to Cold Environment, run by ThermoTrauma at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 14 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Statistical distribution of the temperature evolution (time frame: From the intervention of the medical team on site until discharge from the hospital (1 month maximum)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2026.